The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer.
Identifieur interne : 001733 ( Main/Exploration ); précédent : 001732; suivant : 001734The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer.
Auteurs : Fanghua Qi ; Lin Zhao ; Aiyan Zhou ; Bo Zhang ; Anyuan Li ; Zhixue Wang ; Junqing HanSource :
- Bioscience trends [ 1881-7823 ] ; 2015.
Descripteurs français
- KwdFr :
- Association thérapeutique, Humains, Médecine traditionnelle chinoise, Médicaments issus de plantes chinoises (administration et posologie), Médicaments issus de plantes chinoises (usage thérapeutique), Soins terminaux (), Traitement médicamenteux adjuvant, Tumeurs (), Tumeurs (radiothérapie), Tumeurs (traitement médicamenteux).
- MESH :
- administration et posologie : Médicaments issus de plantes chinoises.
- radiothérapie : Tumeurs.
- traitement médicamenteux : Tumeurs.
- usage thérapeutique : Médicaments issus de plantes chinoises.
- Association thérapeutique, Humains, Médecine traditionnelle chinoise, Soins terminaux, Traitement médicamenteux adjuvant, Tumeurs.
English descriptors
- KwdEn :
- MESH :
- chemical , administration & dosage : Drugs, Chinese Herbal.
- chemical , therapeutic use : Drugs, Chinese Herbal.
- drug therapy : Neoplasms.
- methods : Terminal Care.
- radiotherapy : Neoplasms.
- therapy : Neoplasms.
- Chemotherapy, Adjuvant, Combined Modality Therapy, Humans, Medicine, Chinese Traditional.
Abstract
Recent studies indicate that Traditional Chinese medicine (TCM) can play an important role in the whole course of cancer treatment such as recovery stages of post-operative, radiotherapy or chemotherapy stages instead of only terminal stage of cancer. In this review, we have summarized current evidence for using TCM as adjuvant cancer treatment in different stages of cancer lesions. Some TCMs (e.g., TJ-41, Liu-jun-zi-tang, PHY906, Coumarin, and Aescine) are capable of improving the post-operative symptoms such as fatigue, pain, appetite, diarrhea, nausea, vomiting, and lymphedema. Some TCMs (e.g., Ginseng, Huang-Qi, BanZhiLian, TJ-48, Huachansu injection, Shenqi fuzheng injection, and Kanglaite injection) in combination with chemo- or radio-therapy are capable of enhancing the efficacy of and diminishing the side effects and complications caused by chemo- and radiotherapy. Taken together, they have great advantages in terms of suppressing tumor progression, relieving surgery complications, increasing the sensitivity of chemo- and radio- therapeutics, improving an organism's immune system function, and lessening the damage caused by surgery, chemo- or radio-therapeutics. They have significant effects on relieving breast cancer-related lymphedema, reducing cancer-related fatigue and pain, improving radiation pneumonitis and gastrointestinal side effects, protecting liver function, and even ameliorating bone marrow suppression. This review of those medicines should contribute to an understanding of Chinese herbal medicines as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer, by providing useful information for development of more effective anti-cancer drugs and making more patients "survival with cancer" for a long time.
DOI: 10.5582/bst.2015.01019
PubMed: 25787906
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000F73
- to stream PubMed, to step Curation: 000F73
- to stream PubMed, to step Checkpoint: 000F73
- to stream Ncbi, to step Merge: 007161
- to stream Ncbi, to step Curation: 007161
- to stream Ncbi, to step Checkpoint: 007161
- to stream Main, to step Merge: 001735
- to stream Main, to step Curation: 001733
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer.</title><author><name sortKey="Qi, Fanghua" sort="Qi, Fanghua" uniqKey="Qi F" first="Fanghua" last="Qi">Fanghua Qi</name><affiliation><nlm:affiliation>Department of Traditional Chinese Medicine, Shandong Provincial Hospital affiliated to Shandong University.</nlm:affiliation><wicri:noCountry code="subField">Shandong Provincial Hospital affiliated to Shandong University</wicri:noCountry></affiliation></author><author><name sortKey="Zhao, Lin" sort="Zhao, Lin" uniqKey="Zhao L" first="Lin" last="Zhao">Lin Zhao</name></author><author><name sortKey="Zhou, Aiyan" sort="Zhou, Aiyan" uniqKey="Zhou A" first="Aiyan" last="Zhou">Aiyan Zhou</name></author><author><name sortKey="Zhang, Bo" sort="Zhang, Bo" uniqKey="Zhang B" first="Bo" last="Zhang">Bo Zhang</name></author><author><name sortKey="Li, Anyuan" sort="Li, Anyuan" uniqKey="Li A" first="Anyuan" last="Li">Anyuan Li</name></author><author><name sortKey="Wang, Zhixue" sort="Wang, Zhixue" uniqKey="Wang Z" first="Zhixue" last="Wang">Zhixue Wang</name></author><author><name sortKey="Han, Junqing" sort="Han, Junqing" uniqKey="Han J" first="Junqing" last="Han">Junqing Han</name></author></titleStmt><publicationStmt><idno type="wicri:source">PubMed</idno><date when="2015">2015</date><idno type="RBID">pubmed:25787906</idno><idno type="pmid">25787906</idno><idno type="doi">10.5582/bst.2015.01019</idno><idno type="wicri:Area/PubMed/Corpus">000F73</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000F73</idno><idno type="wicri:Area/PubMed/Curation">000F73</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000F73</idno><idno type="wicri:Area/PubMed/Checkpoint">000F73</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000F73</idno><idno type="wicri:Area/Ncbi/Merge">007161</idno><idno type="wicri:Area/Ncbi/Curation">007161</idno><idno type="wicri:Area/Ncbi/Checkpoint">007161</idno><idno type="wicri:Area/Main/Merge">001735</idno><idno type="wicri:Area/Main/Curation">001733</idno><idno type="wicri:Area/Main/Exploration">001733</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en">The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer.</title><author><name sortKey="Qi, Fanghua" sort="Qi, Fanghua" uniqKey="Qi F" first="Fanghua" last="Qi">Fanghua Qi</name><affiliation><nlm:affiliation>Department of Traditional Chinese Medicine, Shandong Provincial Hospital affiliated to Shandong University.</nlm:affiliation><wicri:noCountry code="subField">Shandong Provincial Hospital affiliated to Shandong University</wicri:noCountry></affiliation></author><author><name sortKey="Zhao, Lin" sort="Zhao, Lin" uniqKey="Zhao L" first="Lin" last="Zhao">Lin Zhao</name></author><author><name sortKey="Zhou, Aiyan" sort="Zhou, Aiyan" uniqKey="Zhou A" first="Aiyan" last="Zhou">Aiyan Zhou</name></author><author><name sortKey="Zhang, Bo" sort="Zhang, Bo" uniqKey="Zhang B" first="Bo" last="Zhang">Bo Zhang</name></author><author><name sortKey="Li, Anyuan" sort="Li, Anyuan" uniqKey="Li A" first="Anyuan" last="Li">Anyuan Li</name></author><author><name sortKey="Wang, Zhixue" sort="Wang, Zhixue" uniqKey="Wang Z" first="Zhixue" last="Wang">Zhixue Wang</name></author><author><name sortKey="Han, Junqing" sort="Han, Junqing" uniqKey="Han J" first="Junqing" last="Han">Junqing Han</name></author></analytic><series><title level="j">Bioscience trends</title><idno type="eISSN">1881-7823</idno><imprint><date when="2015" type="published">2015</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Chemotherapy, Adjuvant</term><term>Combined Modality Therapy</term><term>Drugs, Chinese Herbal (administration & dosage)</term><term>Drugs, Chinese Herbal (therapeutic use)</term><term>Humans</term><term>Medicine, Chinese Traditional</term><term>Neoplasms (drug therapy)</term><term>Neoplasms (radiotherapy)</term><term>Neoplasms (therapy)</term><term>Terminal Care (methods)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Association thérapeutique</term><term>Humains</term><term>Médecine traditionnelle chinoise</term><term>Médicaments issus de plantes chinoises (administration et posologie)</term><term>Médicaments issus de plantes chinoises (usage thérapeutique)</term><term>Soins terminaux ()</term><term>Traitement médicamenteux adjuvant</term><term>Tumeurs ()</term><term>Tumeurs (radiothérapie)</term><term>Tumeurs (traitement médicamenteux)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Drugs, Chinese Herbal</term></keywords><keywords scheme="MESH" type="chemical" qualifier="therapeutic use" xml:lang="en"><term>Drugs, Chinese Herbal</term></keywords><keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Médicaments issus de plantes chinoises</term></keywords><keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Terminal Care</term></keywords><keywords scheme="MESH" qualifier="radiotherapy" xml:lang="en"><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="radiothérapie" xml:lang="fr"><term>Tumeurs</term></keywords><keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Neoplasms</term></keywords><keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Tumeurs</term></keywords><keywords scheme="MESH" qualifier="usage thérapeutique" xml:lang="fr"><term>Médicaments issus de plantes chinoises</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Chemotherapy, Adjuvant</term><term>Combined Modality Therapy</term><term>Humans</term><term>Medicine, Chinese Traditional</term></keywords><keywords scheme="MESH" xml:lang="fr"><term>Association thérapeutique</term><term>Humains</term><term>Médecine traditionnelle chinoise</term><term>Soins terminaux</term><term>Traitement médicamenteux adjuvant</term><term>Tumeurs</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en">Recent studies indicate that Traditional Chinese medicine (TCM) can play an important role in the whole course of cancer treatment such as recovery stages of post-operative, radiotherapy or chemotherapy stages instead of only terminal stage of cancer. In this review, we have summarized current evidence for using TCM as adjuvant cancer treatment in different stages of cancer lesions. Some TCMs (e.g., TJ-41, Liu-jun-zi-tang, PHY906, Coumarin, and Aescine) are capable of improving the post-operative symptoms such as fatigue, pain, appetite, diarrhea, nausea, vomiting, and lymphedema. Some TCMs (e.g., Ginseng, Huang-Qi, BanZhiLian, TJ-48, Huachansu injection, Shenqi fuzheng injection, and Kanglaite injection) in combination with chemo- or radio-therapy are capable of enhancing the efficacy of and diminishing the side effects and complications caused by chemo- and radiotherapy. Taken together, they have great advantages in terms of suppressing tumor progression, relieving surgery complications, increasing the sensitivity of chemo- and radio- therapeutics, improving an organism's immune system function, and lessening the damage caused by surgery, chemo- or radio-therapeutics. They have significant effects on relieving breast cancer-related lymphedema, reducing cancer-related fatigue and pain, improving radiation pneumonitis and gastrointestinal side effects, protecting liver function, and even ameliorating bone marrow suppression. This review of those medicines should contribute to an understanding of Chinese herbal medicines as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer, by providing useful information for development of more effective anti-cancer drugs and making more patients "survival with cancer" for a long time.</div></front></TEI><affiliations><list></list><tree><noCountry><name sortKey="Han, Junqing" sort="Han, Junqing" uniqKey="Han J" first="Junqing" last="Han">Junqing Han</name><name sortKey="Li, Anyuan" sort="Li, Anyuan" uniqKey="Li A" first="Anyuan" last="Li">Anyuan Li</name><name sortKey="Qi, Fanghua" sort="Qi, Fanghua" uniqKey="Qi F" first="Fanghua" last="Qi">Fanghua Qi</name><name sortKey="Wang, Zhixue" sort="Wang, Zhixue" uniqKey="Wang Z" first="Zhixue" last="Wang">Zhixue Wang</name><name sortKey="Zhang, Bo" sort="Zhang, Bo" uniqKey="Zhang B" first="Bo" last="Zhang">Bo Zhang</name><name sortKey="Zhao, Lin" sort="Zhao, Lin" uniqKey="Zhao L" first="Lin" last="Zhao">Lin Zhao</name><name sortKey="Zhou, Aiyan" sort="Zhou, Aiyan" uniqKey="Zhou A" first="Aiyan" last="Zhou">Aiyan Zhou</name></noCountry></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001733 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 001733 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Wicri/Sante
|area= LymphedemaV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= pubmed:25787906
|texte= The advantages of using traditional Chinese medicine as an adjunctive therapy in the whole course of cancer treatment instead of only terminal stage of cancer.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:25787906" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a LymphedemaV1
| This area was generated with Dilib version V0.6.31. |  |